These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29040431)

  • 21. Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways.
    Wang H; Shen W; Hu X; Zhang Y; Zhuo Y; Li T; Mei F; Li X; Xiao L; Chu T
    Breast Cancer Res Treat; 2015 Feb; 149(3):705-14. PubMed ID: 25667102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate.
    Warin R; Xiao D; Arlotti JA; Bommareddy A; Singh SV
    Mol Carcinog; 2010 May; 49(5):500-7. PubMed ID: 20422714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
    Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
    Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells.
    Xiao D; Bommareddy A; Kim SH; Sehrawat A; Hahm ER; Singh SV
    PLoS One; 2012; 7(3):e32597. PubMed ID: 22457718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2010 Jun; 3(6):718-26. PubMed ID: 20484174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
    Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
    Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis.
    Ohshiba T; Miyaura C; Ito A
    Biochem Biophys Res Commun; 2003 Jan; 300(4):957-64. PubMed ID: 12559967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.
    Rahman MM; Veigas JM; Williams PJ; Fernandes G
    Breast Cancer Res Treat; 2013 Oct; 141(3):341-52. PubMed ID: 24062211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.
    Winding B; Misander H; Høegh-Andersen P; Brünner N; Foged NT
    Breast Cancer Res Treat; 2003 Mar; 78(2):205-16. PubMed ID: 12725420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases.
    Lemma S; Di Pompo G; Porporato PE; Sboarina M; Russell S; Gillies RJ; Baldini N; Sonveaux P; Avnet S
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3254-3264. PubMed ID: 28866133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-form RON overexpression augments benzyl isothiocyanate-induced apoptosis in human breast cancer cells.
    Sehrawat A; Singh SV
    Mol Carcinog; 2016 May; 55(5):473-85. PubMed ID: 25857724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
    Kim SH; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo.
    Idris AI; Libouban H; Nyangoga H; Landao-Bassonga E; Chappard D; Ralston SH
    Mol Cancer Ther; 2009 Aug; 8(8):2339-47. PubMed ID: 19671767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
    Harms JF; Welch DR; Samant RS; Shevde LA; Miele ME; Babu GR; Goldberg SF; Gilman VR; Sosnowski DM; Campo DA; Gay CV; Budgeon LR; Mercer R; Jewell J; Mastro AM; Donahue HJ; Erin N; Debies MT; Meehan WJ; Jones AL; Mbalaviele G; Nickols A; Christensen ND; Melly R; Beck LN; Kent J; Rader RK; Kotyk JJ; Pagel MD; Westlin WF; Griggs DW
    Clin Exp Metastasis; 2004; 21(2):119-28. PubMed ID: 15168729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
    Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
    Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.